Canada markets closed

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
21.97-0.94 (-4.10%)
At close: 04:00PM EST
21.00 -0.97 (-4.42%)
After hours: 06:46PM EST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Total Revenue
51,500
12,359
9,539
20,789
Operating Expenses
Research Development
153,403
173,760
57,846
33,640
Selling General and Administrative
45,017
41,451
23,217
12,662
Total Operating Expenses
198,420
215,211
81,063
46,302
Operating Income or Loss
-146,920
-202,852
-71,524
-25,513
Interest Expense
2,919
2,674
831
854
Total Other Income/Expenses Net
2,228
1,099
-263
-32
Income Before Tax
-146,661
-203,674
-72,148
-25,991
Income from Continuing Operations
-146,661
-203,674
-72,148
-25,991
Net Income
-146,661
-203,674
-72,148
-25,991
Net Income available to common shareholders
-146,661
-203,674
-72,148
-25,991
Basic EPS
-
-7.74
-3.55
-2.15
Diluted EPS
-
-7.74
-3.55
-2.15
Basic Average Shares
-
26,317
20,305
12,069
Diluted Average Shares
-
26,317
20,305
12,069
EBITDA
-
-199,807
-70,435
-24,453